TB Research

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019

Angeliki Stathi, Ioanna Loukou, Helen Kirikou, Argyri Petrocheilou, Maria Moustaki, Aristea Velegraki, Levantia Zachariadou

Eurosurveillance · 2019-07

Abstract

We report the first isolation of Candida auris in Greece from a sputum culture of a cystic fibrosis patient in their 20s under posaconazole treatment. The pathogen was identified as C. duobushaemulonii by VITEK2YST, but as C. auris by MALDI-TOF MS . This case underscores the need for species-level identification of all non- albicans Candida (NAC) isolates from cystic fibrosis patients and patients with predisposing factors to fungal infection.

MeSH terms

  • Candida auris
  • Cystic fibrosis
  • Isolation (microbiology)
  • Candida albicans
  • Microbiology
  • Medicine
  • Sputum
  • Pathogen
  • Fungal pathogen
  • Posaconazole
  • Dermatology
  • Antifungal